Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoExecutive summary
Ver el documentoI. Introduction
Abrir esta carpeta y ver su contenidoII. Background on the research project
Abrir esta carpeta y ver su contenidoIII. Second workshop
Abrir esta carpeta y ver su contenidoIV. Preliminary findings
Abrir esta carpeta y ver su contenidoV. Conclusions of the workshop and follow-up plans
Abrir esta carpeta y ver su contenidoAnnex 1: Research proposal
Ver el documentoAnnex 2: List of participants
Ver el documentoAnnex 3: Agenda
Ver el documentoAnnex 4: Questionnaire on NDP performance assessment
Abrir esta carpeta y ver su contenidoAnnex 5: Achievements of the national drug policies in the 12 countries
Ver el documentoAnnex 6: Consolidated tables
Ver el documentoOther documents in the DAP Research Series
 

Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025



Action Programme on Essential Drugs World Health Organization



World Health Organization

WHO/DAP/97.6

Organisation mondiale de la Santé

English only
Distr.: Limited

Comparative analysis of national drug policies in 12 countries

Second workshop
Geneva, 10-13 June 1996
Action Programme on Essential Drugs

Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developed countries. The DAP research series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. The Action Programme has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by the Programme to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the DAP research series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.

© World Health Organization 1997

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).

The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors

This report has been prepared by Mrs Pascale Brudon (WHO Action Programme on Essential Drugs).

She benefited from the comments from all the participants in the workshop, mainly Prof. M. Reich (HSPH Boston) who prepared the paragraphs on political mapping, Ms K. Timmermans, who completed the consolidated tables in Annex 6 and reviewed the country data, Dr A. Reeler who took notes during the workshop, Dr G. Tomson and Dr T. Falkenberg (IHCAR), Dr J.D. Rainhorn (CREDES), Dr R. Govindaraj (HSPH, Boston) and from staff of the Action Programme on Essential Drugs. The researchers at country level (namely, Dr T.V. Benisheva-Dimitrova, Dr E. Carandang, Dr E. Gonzalez-Sedano, Mr M. Fofana, Mr M. Laloge, Mr M. Ndlovu, Mr L. Ngarmadjingaye, Dr Nguyen Thanh Do, Dr G.I. Petrova, Dr G.N.V. Ramana, Dr Sauwakon Ratanawijitrasin, Mr O. Sidibe, Mrs B. Trap, Dr K. Weerasuriya) reviewed the report before finalization and added useful insights.

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 agosto 2014